Breast Cancer and its Management
Future Directions in the Treatment of Patients With HER2+ Breast Cancer: What Community Oncologists Need to Know
Trastuzumab
Newest Approach to Breast Cancer
1 Management of Breast Cancer By Hussein M. Khaled Prof. Medical Oncology Vice President Post graduate Studies and Research Cairo University.
Management of HER2 Over- Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings Christy A Russell, MD Keck School of Medicine University.
Novel Targeted Drugs and Their Introduction to the Clinic Phil Bedard MD, FRCP(C) Division of Medical Oncology/Hematology Drug Development Program.
Acosog Z0011 Cons
Neo-Adjuvant Systemic Treatment: Current Modalities Luc Y. Dirix Medical Oncology Oncologisch Centrum GvA, Antwerp. October 14, 2006.
Controlling the Experimentwise Type I Error Rate When Survival Analyses Are Planned for Subsets of the Sample. Greg Yothers, MA National Surgical Adjuvant.
Surgery Journal Club By : Ahmad Zahmatkesh Mohammadreza Nazemian.
Lectures inEarly Breast Cancer A PowerPoint slide set based on images from: Lectures in Early Breast Cancer Part 2: Management of Early Breast Cancer.
